Concepedia
Statistics
Publications
10
Citations
2K
H-Index
Active since
2005
Affiliations
Vanderbilt University(Current)
Vanderbilt University Medical Center
Dana-Farber Cancer Institute
Kimberly N. Johnson is an author at Vanderbilt University specializing in cell biology, medicine, and health sciences.
Top concepts
MedicineCell BiologyHealthCell SignalingGene ExpressionCell DevelopmentTissue DevelopmentDevelopmental BiologyTranscriptional RegulationOncology
Publications per year
2005–2020
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann, Bojana Jovanović, Xi Chen et al. · PLoS ONE · 2016 · 1.3K citations · Full text
Breast Oncology, Pathology, Neoadjuvant Chemotherapy Selection +16
Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation
Joshua A. Bauer, A. Bapsi Chakravarthy, Jennifer M. Rosenbluth et al. · Clinical Cancer Research · 2010 · 186 citations · Full text
TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer
Brian D. Lehmann, Vandana G. Abramson, Melinda E. Sanders et al. · Clinical Cancer Research · 2019 · 142 citations · Full text
ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy
Kathryn G. Eby, Jennifer M. Rosenbluth, Deborah J. Mays et al. · Molecular Cancer · 2010 · 73 citations · Full text
Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors
Johanna M. Schafer, Brian D. Lehmann, Paula I. González-Ericsson et al. · Science Translational Medicine · 2020 · 71 citations · Full text
Rows per page
1–5 of 10